Program for Accessible Health and Communication (PACE) signed a new grant with TASO – Global Fund HIV/TB (NFM3) in May 2021 that will run up to December 2023. The grant is aligned to the National HIV and AIDS Strategic Plan 2020/2021–2024/2025 to increase productivity, inclusiveness, and well-being of the population by ending HIV and AIDS as an epidemic by 2030 with the following objectives:
- To reduce new HIV infections by 65% among adults and youth, and to reduce new pediatrics HIV infections to less than 5% by 2025.SO3:
- To reduce AIDS-related morbidity and mortality by 2025. SO4:
- To strengthen social and economic protection to reduce vulnerability to HIV and AIDS and to mitigate their impact on people living with HIV, orphans and other vulnerable
The grant covers 19 Districts of Uganda and is clustered as follows:
Bugishu Cluster: Mbale, Sironko, Bulambuli, Manafwa, Budduda and Namisindwa.
Lango Cluster: Dokolo, Amolatar, Lira, Kole, Oyam, Otuke, Alebtong, Apac and Kwani.
Acholi Cluster: Kitgum, Lamwo,Amuru, and Nwoya.
The national HIV estimates show that there were 1,460,000 people living with HIV in 2019. HIV incidence per 1,000 uninfected people of all ages was 1.4, but it was substantially higher in specific sub-populations and locations. The national estimates put HIV prevalence at 5.8% (7.1% among women and 4.3% for men). Among young people aged 15-24 years, HIV prevalence is 2.8% and 1.1% among young women and young men respectively. The estimates also indicate that
53,000 people were newly infected with HIV: 5,700 children aged 0 to 14 years and 48,000 adults aged 15 years and older (among them, 28,000 women aged 15 years and older). Among older adolescents and young people, HIV prevalence is almost four times higher among females than males
The Project Goal: To increase productivity inclusiveness and well-being of the population through ending the AIDs epidemic by 2030.
- Adolescent girls and young women aged 10 -24 years.
- TB contact tracing we target children under five, HIV positive clients, people on prolonged steroid, people on cancer chemotherapy, mulnorished, elderly and diabetes mellitus